BioCryst Announces Berotralstat Expanded Access Program for Patients with Hereditary Angioedema in United States #BioCryst #Biotech #Stocks #Berotralstat #Angioedema #Doctors #Scientists $BCRX  https://t.co/bY6JkvgkUx